News & Updates
Search Research Content
Resource Finder at Kennedy Krieger Institute
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.
|Title||High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.|
|Publication Type||Journal Article|
|Year of Publication||2010|
|Authors||Petri M, Brodsky RA, Jones RJ, Gladstone D, Fillius M, Magder LS|
|Journal||Arthritis and rheumatism|
|Date Published||2010 May|
Monthly intravenous (IV) cyclophosphamide for 6 months has been the standard induction regimen for lupus nephritis, followed by a maintenance regimen of quarterly infusions for 2 years. We undertook this study to compare the efficacy and safety of the standard regimen versus a high-dose IV cyclophosphamide regimen.
|Alternate Journal||Arthritis Rheum.|